Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$831M |
| 2 |
Palo Alto Networks
PANW
|
+$348M |
| 3 |
Visa
V
|
+$347M |
| 4 |
Citigroup
C
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$295M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$638M |
| 2 |
EOG Resources
EOG
|
+$322M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$305M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$289M |
| 5 |
JD.com
JD
|
+$283M |
Sector Composition
| 1 | Healthcare | 19.11% |
| 2 | Consumer Discretionary | 17.28% |
| 3 | Communication Services | 14.32% |
| 4 | Technology | 13.24% |
| 5 | Financials | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
476
DELISTED
NuVasive, Inc.
NUVA
| $14.1M | 0.01% |
291,832
+283,201
| +3,281% | +$13.7M |
|
|
DTEA
477
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $13.6M | 0.01% |
866,967
+193,103
| +29% | +$3.02M |
|
|
ABGB
478
DELISTED
ABENGOA SA SPONSORED ADR REPSTG CL B SHS
ABGB
| $13.5M | 0.01% |
2,899,020
-40,598
| -1% | -$189K |
|
|
ICD
479
DELISTED
Independence Contract Drilling, Inc.
ICD
| $13.4M | 0.01% |
134,763
+705
| +0.5% | +$70.2K |
|
480
Lumentum
LITE
$10.6B
| $13.3M | 0.01% |
+787,566
| New | +$13.3M |
|
|
FEIC
481
DELISTED
FEI COMPANY
FEIC
| $12.9M | 0.01% |
177,071
+48
| +0% | +$3.51K |
|
482
Natera
NTRA
$24.2B
| $12.3M | 0.01% |
+1,143,532
| New | +$12.3M |
|
483
Caesarstone
CSTE
$48M
| $12.2M | 0.01% |
400,712
-8,101
| -2% | -$246K |
|
|
CHS
484
DELISTED
Chicos FAS, Inc.
CHS
| $12M | 0.01% |
763,613
-1,703,365
| -69% | -$26.8M |
|
|
AVDL
485
Avadel Pharmaceuticals
AVDL
$1.51B
| $11.9M | 0.01% |
726,586
+5,626
| +0.8% | +$91.8K |
|
|
BLOX
486
DELISTED
Infoblox Inc
BLOX
| $11.8M | 0.01% |
739,010
+145,291
| +24% | +$2.32M |
|
|
FLOW
487
DELISTED
SPX FLOW, Inc.
FLOW
| $11.8M | 0.01% |
+341,647
| New | +$11.8M |
|
|
MPG
488
DELISTED
Metaldyne Performance Group Inc.
MPG
| $11.8M | 0.01% |
559,773
-215,874
| -28% | -$4.54M |
|
|
FENX
489
DELISTED
Fenix Parts, Inc.
FENX
| $11.7M | 0.01% |
1,755,568
+573,747
| +49% | +$3.83M |
|
490
Seres Therapeutics
MCRB
$163M
| $11.6M | 0.01% |
19,585
+85
| +0.4% | +$50.4K |
|
491
Madrigal Pharmaceuticals
MDGL
$10B
| $11.5M | 0.01% |
189,208
+1,069
| +0.6% | +$65.1K |
|
|
EPRS
492
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $11.5M | 0.01% |
2,593,956
-36,986
| -1% | -$163K |
|
|
KIN
493
DELISTED
Kindred Biosciences, Inc.
KIN
| $11.3M | 0.01% |
2,173,893
+11,726
| +0.5% | +$61K |
|
|
INXN
494
DELISTED
Interxion Holding N.V.
INXN
| $11.2M | 0.01% |
414,476
-86,277
| -17% | -$2.34M |
|
495
Agios Pharmaceuticals
AGIO
$2.1B
| $11.2M | 0.01% |
158,943
+994
| +0.6% | +$70.2K |
|
496
Chord Energy
CHRD
$5.88B
| $10.9M | 0.01% |
1,254,058
-84,573
| -6% | -$734K |
|
497
Ocular Therapeutix
OCUL
$2.22B
| $10.8M | 0.01% |
770,232
+3,953
| +0.5% | +$55.6K |
|
|
FCSC
498
DELISTED
Fibrocell Science Inc.
FCSC
| $10.8M | 0.01% |
187,197
+10,195
| +6% | +$589K |
|
499
LendingClub
LC
$1.89B
| $10.4M | 0.01% |
156,866
-173,374
| -52% | -$11.5M |
|
|
EE
500
DELISTED
El Paso Electric Company
EE
| $10.1M | 0.01% |
+274,300
| New | +$10.1M |
|